This Symposium will be hosted live and available on-demand
September 22-23, 2026
11:00 AM - 3:00 PM ET
Cell and gene therapies are transforming approaches to disease treatment by enabling the modification, replacement, or restoration of cellular and genetic function. Advances in cell engineering, gene editing, vector development, and manufacturing technologies continue to expand the range of diseases that may be addressed through these therapeutic strategies. As new modalities move closer to clinical application, researchers must navigate challenges related to efficacy, scalability, safety, and long-term therapeutic outcomes.
In this symposium, researchers will discuss how cell and gene therapies are identified, evaluated, and developed for translational and clinical applications. Topics will include emerging therapeutic platforms, strategies for improving delivery and targeting, manufacturing considerations, and approaches for advancing promising candidates through preclinical and clinical development. Attendees will gain insight into the scientific, technical, and translational considerations shaping the future of cell and gene therapy research.
Topics to be covered
• Emerging cell and gene therapy platforms
• Gene editing and genome engineering strategies
• Cell engineering approaches for therapeutic development
• Translational challenges in cell and gene therapy research
• Delivery technologies and targeting strategies
• Manufacturing, scale-up, and process development
• Preclinical evaluation and clinical translation
• Future directions in regenerative medicine and advanced therapeutics
 | David Li, PhD |
 | Hirotaka Kuroda, PhD |
 | Nicholas Clarkson, PhD |
